Avon-NCI Progress for Patients (PFP) Awards for Early Phase Clinical Interventions and Biomarkers in Breast Cancer (Limited Competitive Supplements [Revisions] for P30 Cancer Center Support Grants)

The summary for the Avon-NCI Progress for Patients (PFP) Awards for Early Phase Clinical Interventions and Biomarkers in Breast Cancer (Limited Competitive Supplements [Revisions] for P30 Cancer Center Support Grants) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Avon-NCI Progress for Patients (PFP) Awards for Early Phase Clinical Interventions and Biomarkers in Breast Cancer (Limited Competitive Supplements [Revisions] for P30 Cancer Center Support Grants): -The purpose of this limited competition funding opportunity announcement is to solicit revision applications (previously known as competing supplement applications) from the NCI Cancer Center Support Grant (CCSG)(P30) awardees for the 2007 "Avon-NCI Progress for Patients (PFP) Awards Program: A Special Public-Private Initiative in Early Phase Clinical Interventions and Biomarkers in Breast Cancer. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. -This is a limited competition program announcement (with special receipt dates) for revision (i.e., competitive supplement) applications.
Federal Grant Title: Avon-NCI Progress for Patients (PFP) Awards for Early Phase Clinical Interventions and Biomarkers in Breast Cancer (Limited Competitive Supplements [Revisions] for P30 Cancer Center Support Grants)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-07-244
Type of Funding: Grant
CFDA Numbers: 93.39393.394
CFDA Descriptions: Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 05, 2007
Creation Date: Mar 05, 2007
Archive Date: Dec 16, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.395 -- Cancer Treatment Research
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Eligible institutions or organizations are the current NCI Cancer Center Support (P30) awardees (institutions/organizations). All NCI-designated Cancer Center investigators are eligible to apply, so long as the criteria in regard to project responsiveness are met. However, anticipated funding period of the Avon-NCI award should not extend beyond the end date of the 5-year parent P30 project period. Likewise, if investigators from other SPOREs (P50)/ NCI-designated Cancer Centers are included in the application as subcontractors, the funding period of these subcontractors should not exceed their respective parent P30/P50 project period. Applications exceeding this time limit will not be accepted.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com